Alexis Guédon: Cardiovascular Risk Profiles and Outcomes in Patients With Giant Cell Arteritis
Alexis Guédon, Junior Deputy Editor at the European Journal of Preventive Cardiology, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I’m very happy to announce that our latest research article has just been published online ahead of print in the European Journal of Preventive Cardiology!
In this large nationwide cohort study, we examined the cardiovascular risk profiles and outcomes of patients with Giant Cell Arteritis (GCA) compared to matched control populations. Our findings highlight significantly increased risks of MACE, aortic, peripheral arterial, and visceral artery events in GCA patients – underscoring the critical importance of cardiovascular risk management and inflammation control in this population.
Key insights include:
- GCA is associated with elevated risk of major vascular complications.
- Disease activity is associated with major adverse cardiovascular events, highlighting the role of systemic inflammation.
Many thanks to all co-authors and collaborators who made this work possible!
Article: Cardiovascular risk among Giant cell arteritis patients
Authors: Alexis F Guedon, Olivier Espitia, Maxime Beydon, Etienne Ghrenassia, Tristan Mirault, Emmanuel Messas, Florence Tubach, Raphaèle Seror, Franck Boccara, Ariel Cohen, Ruth Frikke-Schmidt, Børge Grønne Nordestgaard, Azeddine Dellal, Olivier Fain, Arsène Mekinian, Fabrice Carrat
Read the Full Article on European Journal of Preventive Cardiology”
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 03:53Nahrwan Masaoodi: Iron Deficiency Can Exist Without Anemia
-
Sep 29, 2026, 03:38Muhammad Yousaf: Iron Deficiency Beyond Diet
-
Sep 29, 2026, 03:21Parvez Ahmed Chowdhury: Synthesizing Aspirin in the Organic Chemistry Lab
-
Sep 29, 2026, 03:12Ahmed Hamandi: Building the Future of Hematopoietic Transplantation in Iraq
-
Sep 29, 2026, 03:09M V Chandrakanth: Aspirin in CRC – Old Drug, New Precision Oncology?
-
Sep 29, 2026, 03:07Caroline Pothet: Advancing Treatment Development in Sickle Cell Disease and Thalassaemia
-
Sep 29, 2026, 02:53Astha Jain: Thalassemia Care Through a Public Health Lens
-
Sep 29, 2026, 02:50Emma Groarke: Starting a New Career Path in Homeland
-
Sep 28, 2026, 19:14Aditya Sharma: An Outstanding Start to the Final Day of VSS 2026!